Overview

* Veeva fiscal Q2 2026 rev rises 17% yr/yr to , beating analyst expectations, per LSEG data

* Adjusted net income for fiscal Q2 beats analyst estimates, per LSEG data

* Co highlights advancements in AI initiatives and strategic partnerships

Outlook

* Veeva ( VEEV ) sees Q3 revenue between $790 mln and $793 mln

* Company expects Q3 non-GAAP EPS between $1.94 and $1.95

* Veeva ( VEEV ) projects FY revenue between $3.134 bln and $3.140 bln

* Company anticipates FY non-GAAP EPS of approximately $7.78

Result Drivers

* AI INITIATIVES - Veeva AI and Veeva Data Cloud are enabling transformational change for life sciences, per CEO Peter Gassner

* VAULT CRM MILESTONES - Two top 20 biopharmas went live with Vault CRM, now with over 100 customers, expanding capabilities

* STRATEGIC PARTNERSHIP - Veeva ( VEEV ) and IQVIA's partnership allows joint customers to use products and services efficiently across commercial and clinical

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $789.08 $768.40

Revenue mln mln (25

Analysts

)

Q2 EPS $1.19

Q2 Beat $333.40 $316.40

Adjusted mln mln (22

Net Analysts

Income )

Q2 Net $200.31

Income mln

Q2 Beat $352.60 $337.90

Adjusted mln mln (24

Operatin Analysts

g Income )

Q2 $265.36

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy", 11 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

* Wall Street's median 12-month price target for Veeva Systems Inc ( VEEV ) is $300.00, about 4.5% above its August 26 closing price of $286.54

* The stock recently traded at 36 times the next 12-month earnings vs. a P/E of 31 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)